York IE Becomes Certified HubSpot Solutions Partner


RevOps for Startups

York IE takes a RevOps-based approach to go-to-market (GTM), supporting the entire buyer journey and creating systems that delight customers while accelerating revenue growth. By joining the HubSpot Solutions Partner Program, the firm is continuing its commitment to reshape the way startups are built, scaled and monetized.

“Footnotes kill funding,” said Sebastian Silva, lead RevOps strategist, York IE. “The earlier a company can build a stable, flexible and consistent data foundation in their CRM, the less work they’ll have to do during funding stages to cobble together and tell their story.”

The firm recently announced it is acquiring Jameson Strategies, a RevOps as a Service consultancy, and offering RevOps services to help early-stage startups create well-defined GTM strategies and build mature tech stacks.

“York IE’s RevOps services have helped us get the most out of our HubSpot instance and streamlined our entire GTM,” said Jorie Basque, head of customer success at Lytica.

If your company is considering HubSpot or other CRM providers, or you need help managing and optimizing HubSpot to accelerate your business, contact York IE’s advisory services team at https://york.ie/services-request/.



Source link

Related articles

Polymarket has reportedly fired its advertising chief, additionally a detailed buddy of the CEO

Main decentralized betting platform Polymarket has fired its chief advertising officer, Matthew Modabber, who can also be a detailed buddy of the corporate’s CEO Shayne Coplan, in keeping with the New York Publish.The...

Oura sues rival Ultrahuman once more, threatening its U.S. sensible ring comeback

Sensible ring maker Oura has sued Indian rival Ultrahuman once more, in search of to dam U.S. gross sales of its Ring Professional (pictured above) simply months after the redesign helped the Bengaluru-based...

Vera Therapeutics, Inc. (VERA) Discusses Ultimate Efficacy Outcomes of ORIGIN Section III Trial of Atacicept in IgA Nephropathy Transcript

Observe Vera Therapeutics, Inc. (VERA) Discusses Ultimate Efficacy Outcomes of ORIGIN Section III Trial of Atacicept in IgA Nephropathy October 22, 2026 4:30 PM EDT Firm Members Marshall Fordyce - Founder,...

New DeepSeek Ban In US, Swiss-Asia Crypto Ties Deepen: Asia Categorical

CHINATreasury proposes blocks on US investments in AI and semiconductors in some international international locationsThe US Treasury has proposed new guidelines that will block funding in synthetic intelligence tasks (sorry, ‘Tremendous Intelligence’ tasks)...

OpenAI has minimize its valuation goal to $1.25T, down from the $1.4T valuation it pitched earlier this month, after going through resistance from some...

Featured Podcasts The Upstarts Podcast: The Parking Startup That Swallowed A 100-Yr-Outdated Big | Metropolis CEO Alex Israel Veteran tech reporter Alex Konrad sits down with breakout entrepreneurs taking over the established order to shake up...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com